CD8A and neoplasm: However, we would like to acknowledge that, due to limitations on the number of antibodies can be used at a time for multiplex IHC analysis, we have focused only on immune cell markers (CD4, CD8, CD45), tumor marker (pan CK), MAPK marker (pp38) and nuclei stain (DAPI).